__timestamp | United Therapeutics Corporation | Walgreens Boots Alliance, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 381287000 | 17992000000 |
Thursday, January 1, 2015 | 452612000 | 22400000000 |
Friday, January 1, 2016 | 316800000 | 23910000000 |
Sunday, January 1, 2017 | 330100000 | 23813000000 |
Monday, January 1, 2018 | 265800000 | 24694000000 |
Tuesday, January 1, 2019 | 336200000 | 23557000000 |
Wednesday, January 1, 2020 | 423900000 | 25436000000 |
Friday, January 1, 2021 | 467000000 | 24586000000 |
Saturday, January 1, 2022 | 487000000 | 27295000000 |
Sunday, January 1, 2023 | 477100000 | 34205000000 |
Monday, January 1, 2024 | 28113000000 |
Unlocking the unknown
In the world of corporate finance, Selling, General, and Administrative (SG&A) expenses are a critical measure of operational efficiency. This analysis compares United Therapeutics Corporation and Walgreens Boots Alliance, Inc. over a decade, from 2014 to 2023.
United Therapeutics has shown a steady increase in SG&A expenses, peaking in 2022 with a 30% rise from 2014. This growth reflects strategic investments in research and development, crucial for a biotech firm.
Walgreens, a retail giant, has consistently maintained higher SG&A expenses, with a notable 44% increase from 2014 to 2023. This trend underscores its expansive retail operations and global reach.
While both companies have distinct operational models, their SG&A trends highlight strategic priorities. Missing data for United Therapeutics in 2024 suggests a need for updated insights.
Selling, General, and Administrative Costs: Novartis AG vs Walgreens Boots Alliance, Inc.
Gilead Sciences, Inc. vs United Therapeutics Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Perrigo Company plc